Stay updated on Nivolumab Frontline + Salvage Nivo + Ipi in Advanced RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Frontline + Salvage Nivo + Ipi in Advanced RCC Clinical Trial page.

Latest updates to the Nivolumab Frontline + Salvage Nivo + Ipi in Advanced RCC Clinical Trial page
- Check3 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.1 to v3.7.2; the page continues to display a 403 error.SummaryDifference0.2%

- Check10 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the study details and preventing access to this trial's information. The error page includes a 403 header and footer, indicating restricted access to the record.SummaryDifference20%

- Check52 days agoChange DetectedA new revision entry v3.6.6 was added to the revision history, and the previous entry v3.6.5 was removed. This reflects an update to the page's versioning information without altering substantive content.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision changed from v3.6.4 to v3.6.5, indicating a new build of the page.SummaryDifference0.0%

- Check88 days agoChange Detected- Revision updated from v3.6.3 to v3.6.4, signaling a minor maintenance update to the page metadata. - No study content or user-facing details appear to be changed.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Frontline + Salvage Nivo + Ipi in Advanced RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Frontline + Salvage Nivo + Ipi in Advanced RCC Clinical Trial page.